Aryn Sands
Bml Capital Management, Llc
Assets Managed
$155.766M
Holdings
16
Last Quarter
2026 - Q1
Filed Date
20d ago
Growth Rate
34.65%(2Q avg: 20.29%)
Sustained Growth
2 quarters
Portfolio positions
This chart displays the top 10 holdings in Bml Capital Management, Llc's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 16 positions.
Assets under management
The assets under management (AUM) of Bml Capital Management, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 2 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 155.766M in assets, with a quarterly growth rate of 34.65% and a 2-quarter average growth rate of 20.29%. The portfolio is managed by Aryn Sands, and others.
Portfolio holdings
| Investment | Portfolio % | Reported Value | Recent Activity |
|---|---|---|---|
ACRS Aclaris Therapeutics Inc
| 34.31% | $53.438M 14.25M shares@ $3.75 avg price | |
AVIR Atea Pharmaceuticals Inc
| 24.38% | $37.976M 7.059M shares@ $5.39 avg price | Decreased -5.75% |
ORMP Oramed Pharmaceuticals Inc
| 6.92% | $10.769M 3.167M shares@ $3.4 avg price | |
TLYS Tilly's Inc-class A Shrs
| 5.6% | $8.707M 2.15M shares@ $4.05 avg price | New Position |
OM Outset Medical Inc
| 4.69% | $7.304M 1.902M shares@ $3.85 avg price | Increased 250.2% |
PMVP Pmv Pharmaceuticals Inc
| 4.24% | $6.597M 5.32M shares@ $1.24 avg price | Increased 0.53% |
KMX Carmax Inc
| 4.14% | $6.445M 155,000 shares@ $41.58 avg price | |
KZR Kezar Life Sciences Inc
| 3.44% | $5.348M 720,787 shares@ $7.43 avg price | |
TIL Instil Bio Inc
| 3.42% | $5.32M 645,600 shares@ $8.24 avg price | |
TGT Target Corp
| 2.92% | $4.545M 37,500 shares@ $121.2 avg price |
1-10 of 16